Fifth Generation Solar Concentrator based on Quantum Dot Technology Launched

Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB:INKN); (OTCBB:INKND), an innovative nanotechnology company announced today that its wholly-owned subsidiary, Shrink Solar LLC, is pleased to unveil the fifth generation of its solar concentrator technology, which is based on the Company's proprietary NanoShrink™ material and its unique photovoltaic quantum dot composition.

The tinted prototype window generates current and functions as a window.

Shrink Solar's fifth generation solar concentrator has achieved higher efficiencies than previous generations of energy producing cells. This design also incorporates additional structures and circuit design to bolster efficiency. The Company believes that as this technology continues to evolve and ultimately is optimized, it will be form fit into existing silicon PV systems for windows, roofing, consumer products and other solar applications. Shrink Solar’s patent-pending fifth generation nano-based technology uniquely filters out wavelengths currently not absorbed by silicon and re-emits them into a device by concentrating light, all without the need for a tracking device, mirror or lens. Shrink Solar has demonstrated this proof-of-concept in an initial solar window prototype device.

“Our fifth generation solar window prototype delivers the necessary proof-of-concept to attract larger, international players in the solar energy sector and ultimately provide the resources to continue to optimize this technology for commercial applications. Because our solar concentrator technologies are easily upgradable and can be designed to be integrated into existing solar installations, existing silicon PV manufacturers as well as window manufacturers are key potential commercial partners. We hope to begin to announce small scale development partnerships in the near future,” said Mark L. Baum, CEO of Shrink Nanotechnologies, Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.